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Abstract: 
Background: The successful percutaneous coronary intervention (PCI) in chronic total 
occlusion (CTO) improves the long-term outcome in patients with coronary artery disease 
(CAD). Heavy calcification remains one of the strongest predictors of an unfavorable 
outcome of PCI. In this case series study, shockwave intravascular lithotripsy (S-IVL)-a novel
balloon-based coronary system facilitating modification of calcified coronary lesions was 
evaluated. 
Methods: The study population consisted of five heavily calcified, undilatable-CTOs lesions 
treated with S-IVL selected out of all consecutive CTO-PCI patients performed at two high-
volume cardiac centers. 
Results: The registry included 5 patients successful CTO — S-IVL procedures with an 
average J-CTO of 2.6 points. In the short-term follow-up period, including the first 30 days, 
no cases of acute in-stent thrombosis, target lesion failure, or major adverse cardiac and 
cerebrovascular events were noted. 
Conclusions: The present data suggest that this approach can be safe and useful in the 
treatment of complex calcified CTO lesions.
Key words: chronic total occlusion (CTO), coronary artery disease (CAD), percutaneous
coronary intervention (PCI), shockwave intravascular lithotripsy (S-IVL), calcified 
lesions, undilatable lesions; chronic stable angina
Introduction
A coronary chronic total occlusion (CTO) is defined as complete occlusion of a 
coronary artery for a duration of greater than 3 months based on angiographic evidence. 
Approximately one-quarter of patients undergoing diagnostic coronary angiography, CTO-
lesions can be found [1, 2]. Advances in the percutaneous coronary intervention (PCI) 
techniques in the management of CTO have improved the success rate of this procedure in 
over 80% of high-volume expert centers, however, data from the “real-life” registry suggests 
that the success rate is far below the mentioned level, achieving approximately 60% [3]. As it 
was proven, the successful CTO PCI procedure improves the long-term outcome of patients 
with coronary artery disease (CAD) [4]. Despite apparent clinical benefits, the risk of 
complications associated with these complex PCI procedures is significantly higher, 
compared to the non-CTOs [5]. 
To have better planning and to predict the short-term outcome, the J-CTO-score was 
proposed as an angiographic scale of the degree of difficulty of CTO-PCI [6]. One of five 
variables that increase the difficulty of the PCI-CTO procedure, in this well-validated scale, is
the presence of calcifications in the body of the occlusion. A similar relationship between 
target lesion calcification and clinical outcome is observed in non-CTO PCI procedures [7]. 
The crucial mechanism leading to these unfavorable results is mainly connected with short- 
and long-term stent failure (fracture, poor expansion, malapposition followed by an increased 
rate of stent thrombosis and in-stent restenosis). Furthermore, calcifications increase the rate 
of peri-procedural complications particularly, life-threatening coronary artery perforation [8].
A proper lesion preparation before stent implantation has been established as a 
prerequisite to achieving adequate PCI results. Numerous strategies aimed at the crossing and 
appropriate preparation of calcified plaques have been implemented in the CTO-tool box [9]. 
Conventional procedures were divided into the balloon-dependent group (non-compliant 
[NC], ultrahigh-pressure balloon (OPN) or cutting/scoring catheter) exerting an internal 
pressure on the lesion, and atherectomy devices (rotational, laser, and orbital) focused on 
removing (pulverizing) the atherosclerotic plaque. Therefore, calcified lesions continue to be 
one of the most challenging CTO interventions, where optimal angiographic results and 
satisfying long-term outcomes are hard to achieve. 
A recent study [10] suggests that shockwave intravascular lithotripsy (S-IVL) 
(Shockwave Medical Inc., Fremont, United States) a novel balloon-based coronary system 
converting electrical energy into mechanical force (acoustic wave with high-pressure 
amplitude) can facilitate modification of heavily calcified coronary lesions. Presented herein 
is early real-world experience with the S-IVL device in the setup of the CTO procedure.
Methods
The study population consisted of five carefully selected cases out of all consecutive 
patients with clinical indications for CTO- PCI at the documented cardiac centers from May 
2019 to April 2021. All patients were treated in two high-volume interventional cardiology 
centers (conducting over 1000 PCI procedures each annually). From all pre-screened cases 
(192), patients were selected with mild and severe calcification (102 patients). Calcific 
deposits were assessed by angiography as mild (spots), moderate (involving ≤ 50% of the 
reference lesion diameter), and severe (involving > 50% of the reference lesion diameter). 
From this group, patients with “undilatable” lesions were selected. For the purpose of this 
paper the balloon undilatable, CTOs lesions were defined as lesions after the successful 
crossing of a guidewire through the CTO-body and initial successful pre-treatment with a low 
diameter NC balloon (NCB) catheter or with rotational atherectomy (RA) (4 cases of RA in 
prescreened 192 CTO procedures — all performed due “uncrossable” lesion with a low-
profile balloon catheter or microcatheter) with coexisting significant (over 20% of the 
diameter) under expansion with NCB size 1:1 to vessel diameter inflated with high-pressure 
inflation at least of 20 atm. 
There were no angiographic exclusion criteria regarding lesion anatomy such as the 
length, tortuosity, severity, prior stent placement or, J-CTO score. Figure 1 provides the 
details on the “lesion-related” angiographic and periprocedural inclusion criteria to this 
registry. Safety parameters, including coronary perforation, no-reflow, ventricular 
arrhythmias, and the major adverse cardiac and cerebrovascular events (MACCE) that 
occurred in-hospital and 30-day after primary hospitalization, were recorded. MACCE was 
defined as a composite endpoint including acute coronary syndrome, cerebrovascular events, 
major bleeding, need for repeated revascularization, or death. 
Ethical review and approval were waived for this study due to the fact that it is a 
retrospective analysis of clinical cases and the techniques used in this study were used as bail-
out techniques in order to save lives, however, patient written informed consent for PCI 
procedure was given as well as the use of patient information and images.
Case 1
A 66-year-old female with hypertension, hyperlipidemia, diabetes type 2, history of no
ST-segment elevation myocardial infarction (NSTEMI) 1 year prior, treated with PCI and 
three drug eluting stent (DES) implantations to the left anterior descending (LAD) and D1, 
was admitted to our center to perform the stage procedure of CTO- right coronary artery 
(RCA) (J-CTO score 3 points) (Fig. 2.1a) due to recurrent angina (Canadian Cardiovascular 
Society [CCS] II) and confirmed myocardial viability in transthoracic echocardiogram 
(transthoracic echocardiography with the left ventricular ejection fraction 60%). PCI was 
performed via right femoral access (AL 1.0 7F) and contralateral injection by left radial JL 4,0
(6F). 
Using several guidewires Fielder XT (Asahi-INTECC); Progress 140 (Abbott 
Vascular, Santa-Clara, United States) the distal part of RCA with Gaia3 (Asahi-INTECC) was 
achieved. Despite the use of the 7F guiding extension Guidezilla (Boston Scientific, 
Marlborough, United States) all attempts of crossing the lesion with the microcatheter and a 
low-profile balloon 1.0 mm × 10 mm failed. Considering the severe calcifications, the 
successful crossing of a lesion was achieved with Turnpike Gold135(Vascular Solutions LLC, 
Minneapolis, United States) — microcatheter with threaded tip. In the next step multiple 
successful high-pressure inflation was performed (Fig. 2.1b) with balloon catheters 1.0 mm × 
10 mm; 1.5 mm × 15 mm, and NCB 2.5 mm × 15 mm. 
Despite lesion preparation we observed a significant “dogbone effect” on the NCB 3.0 
mm × 15 mm (21 atm.) (Fig. 2.1c). Hence, the S-IVL using a 3.0 mm × 12 mm catheter was 
performed. Delivery of the device was facilitated by guide extension. After the application of 
80 ultrasonic pulses, full expansion was obtained (Fig. 2.1d). Three overlapping DES 3.5 mm 
× 15 mm; 3.0 mm × 38 mm and 3.0 mm × 38 mm (16 atm.) implantation was followed by a 
3.5 mm × 20 mm (22 atm.) and 3.75 mm × 8 mm (20 atm.) NCB post-dilation. Finally, a 
satisfying angiographic result was obtained (Fig. 2.1e).  
Case 2
An 80-year-old female with hypertension, hyperlipidemia, diabetes type 2, paroxysmal
atrial fibrillation, history of ischemic stroke was admitted to the cath-lab presenting NSTEMI.
Coronary angiogram revealed heavily calcified significant long lesion of the dominant RCA 
with coexisting chronic occlusion of LAD (J-CTO score 3 points) (Fig. 2.2a) due to ongoing 
ischemia (resting chest pain) rescue PCI of RCA with three DES implantation was performed 
via right radial (AL 1.0 6F). 
Five days later due to recurrent angina despite optimal medical therapy, CTO of LAD 
via left radial access was performed (EBU 7F). After wiring a distal part of the LAD with 
microcatheter and Gaia Second (Asahi-INTECC). Flow to artery was restored by inflation of 
1.5 mm × 20 mm balloon catheter and 2.5 mm × 15 mm NCB (Fig. 2.2b). However, 
significant under-expansion of NCB 3.5 mm × 15 mm was observed in the proximal part of a 
lesion (Fig. 2.2c). 
Hence, S-IVL (3.5 × 12 mm) with full expansion after 40 pulses of therapy was 
performed (Fig. 2.2d) and subsequent rapture of S-IVL balloon catheter without any sequelae.
Three overlapping DESs: 2.5 mm × 32 mm; 3.0 mm × 24 mm, and 3.5 mm × 16 mm were 
implanted with final post‐dilated with 3.5 mm NCB (22 atm.) and Thrombolysis in 
Myocardial Infarction 3 flow at the end of the procedure (Fig. 2.2e).
Case 3
A 66-year-old female, with hypertension, hyperlipidemia, diabetes type 2, with lower 
extremity peripheral artery disease (PAD), history of myocardial infarction with ST-segment 
elevation (STEMI) treated percutaneously with implantation of three DES to RCA, with 
subsequent scheduled implantation of three DES to LAD 11 years ago, was admitted to 
hospital with the symptoms of dyspnea and chest pain (II class in the CCS scale) despite 
optimal medical therapy. Magnetic resonance imaging revealed persistent viability of 
myocardium in the area of the inferior wall. 
Coronary angiogram revealed: chronic total occlusion of RCA in previously implanted
stents (Fig. 2.3a) with no significant lesion in the left coronary system. By right radial access 
CTO-PCI was performed with successful crossing lesion with Gaia Second (Asahi-INTECC), 
after an exchange of guidewires the flow in RCA was restored with 1.0 mm × 15 mm (18 atm)
baloon catheter (Fig. 2.3b). However, significant underexpansion of NCB 3.5 mm × 15 mm 
balloon catheter at 22 atm in proximal stent was observed (Fig. 2.3c). Therefore the S-IVL 
catheter 3.5 mm × 12 mm was used. After the application of 80 ultrasonic pulses, full 
expansion was obtained (Fig. 2.3d). In the next step in the previously implanted DES, NCB 
4.0 mm × 15 mm was performed (22 atm.) with subsequent implantation DES 4.0 mm × 15 
mm (16 atm.). 
After restoring a flow to RCA a significant lesion in the distal part of RCA was 
revealed. It was predilatated with NCB 2.5 mm × 15 mm (16 atm.) and was followed by DES 
2.75 mm × 15 mm (14 atm.) implantation. Finally, a satisfying angiographic result was 
obtained (Fig. 2.3e).
Case 4 
62-year-old female with hypertension, hyperlipidemia, rheumatoid arthritis and 
hypothyroidism was admitted to hospital due to recurrent angina class II CCS. Pre-PCI 
echocardiography revealed mild contractility disorders in the area of the intraventricular 
septum with preserved global ejection fraction of the left ventricular. Coronary angiogram 
revealed CTO of the middle part of LAD (J-CTO score 3) (Fig. 2.4a). 
PCI via right femoral access Ebu 3.5 7F and contralateral injection by right radial 
AL1.0 was performed (7F). Using the anterograde wire escalation technique the distal part of 
LAD was achieved with Progress 140 (Abbott Vascular) and microcatheter. The flow was 
restored by inflation of balloon catheter 2.0 mm × 15 mm (16 atm.) (Fig. 2.4b). Despite 
previous lesion preparation, a significant “dogbone effect” on the NCB 3.5 mm × 20 mm 
(22atm.) (Fig. 2.4c) was observed. Thus, the S-IVL catheter 3.5 mm × 12 mm was used and 
after the application of 30 ultrasonic pulses, full expansion was obtained (Fig. 2.4d). Three 
overlapping DESs 3.5 mm × 18 mm; 3.0 mm × 48 mm and 2.5 mm × 18 mm (16 atm.) 
implantation was followed by a 4.0 mm × 8 mm (22 atm.) NCB postdilation. Finally, a 
satisfying angiographic result was obtained (Fig. 2.4e).
Case 5
68-year-old male with hypertension, hyperlipidemia, diabetes type 2, history of 
NSTEMI 6 months prior treated with PCI and DES implantation to the LAD and circumflex 
artery was admitted to hospital to perform stage CTO-RCA (J-CTO score 2) (Fig. 2.5a). 
Control echocardiography revealed slight contractility disorders in the area of the inferior wall
with preserved left ventricular systolic function (ejection fraction 50%). 
Percutaneous coronary intervention was performed via right radial access AL 1.0 7F 
with contralateral injection by left radial Ebu 3.5 7F. The CTO lesion was crossed with Gaia 
Third (Asahi-INTECC) and microcatheter, after wire exchange on extra support successful 
predilatation of a lesion with inflation 1.5 mm × 20 mm balloon catheter and 2.5 mm × 15 
mm NCB was performed (Fig. 2.5b). However significant underexpansion of NCB 3.5 mm × 
20 mm (22 atm) was observed (Fig. 2.5c). As result, the S-IVL 3.5 mm × 12 mm balloon was 
then passed and 4 cycles of lithotripsy were delivered (Fig. 2.5d). Two overlapping DES were 
implanted to RCA — 3.5 mm × 26 mm(16 atm.); 3.5 mm × 40 mm(14 atm.). Additional 
postdilatation with NCB 4.0 mm × 15 mm (20 atm.) was performed. Due to what was 
revealed in control angiogram, a significant lesion in the distal part of RCA after predilatation 
with 3.0 mm × 15 mm NCB, thus DES 3.0 mm × 24 mm was implanted with reasonable 
angiographic resolution (Fig. 2.5e).
Results
The present case-series registry includes 5 patients with successful CTO procedures 
with heavy calcifications within the CTO — body which primary was undilatable with NCB 
treated with S-IVL (Table 1). Details on the clinical, procedural, and postprocedural 
characteristics are provided. All the patients were at “difficult” or “very difficult” stage in the 
degree of difficulty according to the J-CTO with an average of 2.6 points. On average, 
patients undergoing the CTO procedure received 242 mL (140 mL – 320 mL) of contrast — 
no postprocedural renal failure was noticed and absorbed 1543 mGy (1382 mGy – 1657 mGy)
of radiation. In 1 case peri-procedural complication occurred. After the application of 40 sonic
pulses, an S-IVL balloon catheter rapture we observed without any consequences for the 
patient. In the short-term follow-up period including the first 30 days, no cases of acute in-
stent thrombosis or target lesion failure were noted. There was no case of the in-hospital 
MACCE nor MACCE observed within the 30 days after the intervention. The majority of 
procedures were performed by the radial approach (7F)
Discussion
This is, according to available research, is among the first-in-man case series studies to
demonstrate the efficacy and safety of use S-IVL during the PCI-CTO procedures in CAD. So
far, in the literature, mainly single case reports can be found [11, 12] and one recently 
published higher number study [13] using the intravascular lithotripsy as a part of the 
armamentarium in CTO procedures. Data suggest that undergoing successful CTO 
revascularization, compared to unsuccessful CTO recanalization, is associated with clinical 
benefit as well as improvement in long-term outcome [14]. As it was revealed, heavy 
calcifications are associated with lower success rate, and higher complication rates of CTO 
procedures [15]. Unsuccessful crossing through the occlusion with a guidewire is the most 
common mechanism of CTO-PCI failure [16]. However, another frequently observed 
mechanism of the CTO-PCI failure is device-uncrossable CTO lesions, defined as an inability 
of passage of a balloon after successful guidewire crossing (balloon uncrossable lesions) or an
inability to expand fully the catheter despite the use of multiple balloon inflations (balloon 
undilatable lesions). For lesions that are not balloon-crossable, rotational atherectomy or 
orbital atherectomy are justifiable options. Balloon undilatable lesions are technically 
demanding and associated with worse outcomes. Prevalence of this phenomena is rater 
common (6–12% of all CTO procedures) [17, 18]. 
Adequate preparation in such lesions is critical to avoid the short- and long-term 
complications. When inadequate, it can result in suboptimal stent expansion or fracture as 
well as a higher rate of stent thrombosis and in-stent restenosis. Currently, there are several 
therapeutic options to manage this clinical problem. Armamentarium for calcified lesion 
preparation is varied and consists of specialized balloon technology or atherectomy devices. 
Recently McQuillan et al. [19] proposed a clinical algorithm of different techniques that can 
be used in resistant lesions. The first line in the step-wise approach, using a different kind of 
balloon catheter was proposed. Besides classical NCBs, their algorithm recommends the use 
of ultrahigh‐pressure balloons — OPN balloon or cutting/scoring balloons. As a second line, 
they suggest using an atherectomy device (rotational, orbital, or laser). In case of failure,  the 
use of the S-IVL device is proposed, although as it was mentioned before there are only a few 
reports [20, 21] of such complex procedures. Such a stepwise approach allows for increasing 
the number of successful procedures, however, it increases the periprocedural complication 
rate. Especially when a more invasive strategy is used [22]. 
Unlike in the case of balloon uncrossable lesions where calcification occurs mainly 
superficially, causing occlusion of the inner lumen of the vessel, balloon undilatable lesions 
are more likely associated with the presence of profound calcium deposits. Therefore, 
classical methods of lesion preparation-balloon or atherectomy devices focused on the 
superficial plaque modification often remains insufficient. To date, the main method of 
management with these issues has been based on an escalation of device sizes. It was 
inextricably linked with the increased rate of acute peri-procedural complications: slow/no 
flow phenomena, dissection, or perforation of the vessel. Furthermore, this aggressive 
approach often requires the use of femoral access. It may partially result from better guide 
support and the necessity of larger burr size use. On the one hand, recent data suggests [23] 
that trans radial access is increasingly being used for CTO PCI and is associated with a 
similar outcome and a lower rate of major bleeding. On the other hand, a higher level of J-
CTO score accompanied by an increased level of calcium deposits is responsible for the 
growth of the femoral access rate. By using S-IVL devices, it is possible to pass-by the use of 
an atherectomy device (with potentially large burr size) and potentially de-escalate the level 
of necessary “support need” from the guiding catheter which results in an increased rate of 
radial access procedures. The data from our case series seems to be consistent with this thesis 
— despite quite a high average J- CTO score (2.4) a majority of cases were performed by 
radial access (7F). This benefit of the S-IVL device is related to the mechanism of action 
which is a combination of several physical phenomena: amplitude of the pressure, stretching 
wave, cavitation, and lead to the defragmentation of deep calcium nodules [24]. In conclusion,
S-IVL should rather be chosen instead of rotational devices in non-critical focal lesions with 
deep calcium deposits, particularly not susceptible to the predilatation NCB parallel to the 
vessels size. Initial data from real-life registries seems to support this thesis [25]. Despite all 
of this, the bulky nature of S-IVL must be taken into consideration, before proper guiding 
selection. Operators should also be aware of the size limitations of the S-IVL system (short 12
mm balloon catheters in diameter range 2.5–4.0 mm) and a restrained number of delivered 
ultrasonic pulses (80).
Since intravascular lithotripsy is a relatively novel method, safety concerns are not 
unfounded. In our registry, only one acute complication related to this device was observed —
the burst of the S-IVL balloon. This device failure was described previously, it is rather 
common and  hardly ever causes any sequelae [25, 26]. Nevertheless, some data suggest that 
S-IVL can induce ventricular arrhythmias [27] and future studies focused on the safety issue 
of this therapy are necessary. However, in the present “real-life” study, there is a lack of data 
from intravascular imaging (the decision to use intravascular ultrasound/optical coherence 
tomography was left to the discretion of the operators), it was presumed that it would provide 
valuable and precise information to increase the safety and efficacy of CTO-S-IVL 
procedures. 
Although experience with S-IVL and calcified CTO lesion is unproven and limited 
mainly to lower limb arteries [28], the present early experience is favorable and provides 
encouraging preliminary data for future studies. Despite the current lack of strong data, the 
present case study suggests that S-IVL can be effective and safe to handle the balloon-
undilatable lesions in the CTO.
Conclusions 
In this case series describing the application of S-IVL in the PCI-CTO procedures, it 
was shown that the device was a useful tool to assist interventional cardiologists in complex 
calcified CTO lesions.
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Table 1. Clinical, procedural, and postprocedural characteristics of patients.
CAD-CSS II — stable coronary artery disease in second class according to Canadian Cardiovascular Society; 
DES — drug eluting stent; FEM — femoral; IVL — intravascular lithotripsy; J-CTO — Japanese Multicenter 
CTO Registry; LAD — left anterior descending; MACCE — major adverse cardiac and cerebrovascular events; 
RAD — radial; RCA — right coronary artery; UA — unstable angina
Figure 1. Lesion-related angiographic and procedural inclusion and exclusion criteria to 
the study; CTO — chronic total occlusion; CCS — Canadian Cardiovascular Society 
scale; NC — non-compliant; S-IVL — shockwave intravascular lithotripsy; PCI —
percutaneous coronary intervention.
Clinical data Case 1 Case 2 Case 3 Case 4 Case 5
Age 66 80 66 62 68
Hypertension Yes Yes Yes Yes Yes
Type 2 diabetes mellitus Yes Yes No No Yes
Hyperlipidemia Yes Yes Yes Yes Yes
Atrial fibrillation   No Yes No No No











Treated vessel RCA LAD RCA LAD RCA
Access 7F FEM 7F RAD 7F RAD 7F FEM 7F RAD
J-CTO score 3 3 1 3 2
Syntax score 10 29,5 10 15,5 14
IVL diameter [mm] 3.0 3.5 3.5 3.5 3.5













Amount of contrast 
[mL]
140 300 150 320 300
Radiation dose [mGy] 1657 1416 1382 1649 1611
Fluoroscopy time [min] 26.2 24.1 17.5 22.4 37.5
Figure 2. Series of cases: intervention images Case I: 1a. Primary chronic total occlusion 
(CTO) lesion; 1b. Undilatable lesion; 1c. Underexpansion of 3.0 mm × 15 mm non-
compliant balloon (NCB); 1d. Shockwave intravascular lithotripsy (S-IVL) balloon 3.0 
mm × 12 mm; 1e. Final angiogram; Case II: 2a. Primary CTO lesion; 2b. Undilatable 
lesion; 2c. Underexpansion of 3.5 mm × 15 mm NCB; 2d. S-IVL balloon 3.5 mm × 12 
mm; 2e. Final angiogram; Case III: 3a. Primary CTO lesion; 3b. Undilatable lesion; 3c. 
Underexpansion of 3.5 mm × 15 mm NCB; 3d. S-IVL balloon 3.5 mm × 12 mm; 3e. 
Final angiogram; Case IV: 4a. Primary CTO lesion; 4b. Undilatable lesion; 4c. 
Underexpansion of 3.5 mm × 20 mm NCB; 4d. S-IVL balloon 3.5 mm × 12 mm; 4e. 
Final angiogram; Case V: 5a. Primary CTO lesion; 5b. Undilatable lesion; 5c. 
Underexpansion of 3.5 mm × 20 mm NCB; 5d. S-IVL balloon 3.5 mm × 12 mm; 5e. 
Final angiogram.


